... to their PCP will find MC to be more effective, use less delta-9-tetrahydrocannabinol (THC) and more cannabidiol (CBD), and experience fewer side effects. Methods: Through an online survey, medical cannabis users reported their cannabis usage patterns, health outcomes, PCP awareness, and collaboration...

... is the use of cannabis to reduce/treat chronic pain disorders based on anecdotal accounts and the function of its phytocannabinoids. The two main cannabinoids in cannabis, tetrahydrocannabinol (THC) and cannabidiol, act on CB1 and CB2 receptors (in addition to several additional receptors). It is through...

...Iman E. Taha; Mahmoud A. ElSohly; Mohamed M. Radwan; Sundus Omari; Michael A. Repka; Eman A. Ashour Introduction: Cannabidiol (CBD) has sparked considerable interest because of its wide range of pharmacological uses and the fact that it does not induce psychoactive effects. CBD formulation...

... months after the start of the treatment with insulin, cannabidiol (CBD)-enriched extract in handmade olive oil, tetrahydrocannabinol: CBD ratio = 1:24, was incorporated. The route of administration was oromucosal. After 3 months, the glycemia was reduced. The patient decreased the polyuria/polydipsia...

... properties. CBMFs are often considered as novel therapeutic anxiolytic agents that can be prescribed as pharmacotherapy for symptomatic domains in anxiety disorders (ADs). Our aim was to explore effectiveness and tolerability of enriched cannabidiol (CBD) oil extract formulations in adults with anxiety...

...Cristian E. Navarro; Juan C. Pérez Introduction: Neuropsychiatric symptoms (NPS) may be disruptive and problematic for patients with Alzheimer’s disease (AD) and for their caregivers. Cannabidiol (CBD) may be a safer alternative. The objective was to evaluate whether CBD-rich oil was effective...

... and April 2, 2023. Methods: The Lion Poll omnibus survey asked questions of adult-aged Pennsylvanians to assess awareness of cannabidiol (CBD) and products containing tetrahydrocannabinol (THC), including marijuana, the likelihood of reporting cannabinoid use to health care providers (HCPs), and perceptions...

... of patients, highlighting the need for new therapeutic options. Cannabidiol (CBD), a non-psychoactive cannabinoid derived from Cannabis sativa L., has shown potential in reversing psoriasis pathology through its action on skin receptors in preclinical studies. Given the promising properties of CBD...

...Qingchen Zhang; Philip W. Melchert; John S. Markowitz Introduction: Cannabidiol (CBD) is a widely utilized nonpsychoactive cannabinoid available as a prescriptive drug treatment and over-the-counter supplement. In humans, CBD is metabolized and forms the major active metabolite 7-hydroxy...

...Mahmoud A. ElSohly; Iram Shahzadi; Waseem Gul Introduction: Cannabidiol (CBD) has several potential benefits and therapeutic uses, especially in pain, inflammation, and anxiety. CBD has high hydrophobicity and very low solubility in water. CBD has also shown exceptionally low oral-gastrointestinal...

..., instructions or products referred to in the content or advertisements. 2023 Cannabis Clinical Outcomes Research Conference Conference proceedings Medical marijuana Cannabis Cannabinoids Cannabidiol Marijuana efficacy Marijuana clinical outcomes Mental health Public health All but three...

...Robert Kaufmann; Amber Harris Bozer; Amanda Kube Jotte; Keith Aqua Introduction: Self-dosing of off-the-shelf cannabidiol (CBD) for a myriad of health conditions is common in the USA. These CBD products are often mislabeled, suggesting that much less or much more CBD is being consumed than...

...Paul Glare; Richard Chye; Mark Bloch; Mark Arya; Andrew Moore; John Montgomery Introduction: The aim was to demonstrate the safety and tolerability of cannabidiol (CBD) with Δ9-THC in patients with moderate to severe chronic back or neck pain unresponsive to over-the-counter non-opioid analgesics...

...Edward Y. Liu; Kenneth L. McCall; Brian J. Piper Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome. The use...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Cannabis Marijuana Cannabidiol Tetrahydrocannabinol Chronic pain Dosing Key Points The lack of clinical data and dosing recommendations for medical cannabis...

...Robert Kaufmann; Amber Harris Bozer; Amanda Rose Kube Jotte; Keith Aqua Introduction: Previous research indicated that cannabidiol (CBD) may result in low levels of male total testosterone (TT), elevations in liver tests (LTs), and daytime drowsiness (DD). We investigated the prevalences of TT...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Cannabis Marijuana Cannabidiol Tetrahydrocannabinol Driving Impairment Driving under the influence of cannabis has been identified as a public health...

...) and Alzheimer’s (AD) diseases, the two most prevalent neurological diseases. The review goes from Cannabis sativa and its hundreds of bioactive compounds to Δ 9 -tetrahydrocannabinol (THC) and mainly cannabidiol (CBD) and their interactions with the endocannabinoid receptors (CB1 and CB2). CBD molecular targets...

...John S. Markowitz; Ludmila De Faria; Qingchen Zhang; Philip W. Melchert; Reginald F. Frye; Brandon O. Klee; Yuli Qian Introduction: Cannabidiol (CBD) is a widely utilized nonpsychoactive cannabinoid available as an over-the-counter supplement, a component of medical cannabis, and a prescriptive...

... marijuana Cannabis Cannabinoids Cannabidiol Marijuana efficacy Marijuana clinical outcomes Currently, some form of cannabis is legal in all but three states in the USA [1]. Florida approved cannabis, referred to as medical marijuana in the state legislation, for persons with qualifying...